Revvity Stock Performance
| RVTY Stock | 126.84 3.32 2.69% |
Revvity has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 0.54, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Revvity's returns are expected to increase less than the market. However, during the bear market, the loss of holding Revvity is expected to be smaller as well. Revvity right now holds a risk of 1.97%. Please check Revvity potential upside, accumulation distribution, period momentum indicator, as well as the relationship between the expected short fall and day median price , to decide if Revvity will be following its historical price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Revvity are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Revvity is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (1.65) | Five Day Return 0.44 | Year To Date Return 10.29 | Ten Year Return 170.23 | All Time Return 3.6 K |
Forward Dividend Yield 0.0022 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 0.28 | Dividend Date 2025-05-09 |
1 | Acmetek Global Solutions Welcomes Bridgette Matich as Senior Sales Executive | 11/05/2024 |
| Revvity dividend paid on 8th of November 2024 | 11/08/2024 |
2 | Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK | 11/20/2024 |
3 | Disposition of 18365 shares by Prahlad Singh of Revvity at 81.29 subject to Rule 16b-3 | 12/02/2024 |
4 | Disposition of tradable shares by Gonzales Anita of Revvity at 115.94 subject to Rule 16b-3 | 12/16/2024 |
5 | Revvity Inc to Present at J.P. Morgan Healthcare Conference | 12/17/2024 |
6 | Cell Harvesting Systems Market to Cross Revenues of 26.6 Billion by 2034 - Evolving Healthcare Landscape Spurs Demand for Regenerative Medicine and Cell-Based T... | 01/08/2025 |
7 | Revvity Announces FDA Clearance for First Automated Free Testosterone Test | 01/10/2025 |
8 | Revvity Inc Trading 5.83 percent Higher on Jan 13 | 01/13/2025 |
9 | Lab Automation Market Investment Opportunities A Guide to 2031 Tecan Trading AG, PerkinElmer Inc. | 01/14/2025 |
10 | Laboratory Information Management System Market Size to Hit USD 4.61 Billion by 2032, Growing at a CAGR of 8.12 percent - SNS Insider | 01/17/2025 |
| Begin Period Cash Flow | 470.7 M |
Revvity |
Revvity Relative Risk vs. Return Landscape
If you would invest 12,097 in Revvity on November 1, 2024 and sell it today you would earn a total of 587.00 from holding Revvity or generate 4.85% return on investment over 90 days. Revvity is currently generating 0.098% in daily expected returns and assumes 1.9711% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than Revvity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Revvity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Revvity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Revvity, and traders can use it to determine the average amount a Revvity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0497
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RVTY | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.97 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Revvity is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Revvity by adding it to a well-diversified portfolio.
Revvity Fundamentals Growth
Revvity Stock prices reflect investors' perceptions of the future prospects and financial health of Revvity, and Revvity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Revvity Stock performance.
| Return On Equity | 0.0331 | ||||
| Return On Asset | 0.0172 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 17.37 B | ||||
| Shares Outstanding | 121.7 M | ||||
| Price To Book | 1.93 X | ||||
| Price To Sales | 5.62 X | ||||
| Revenue | 2.75 B | ||||
| Gross Profit | 1.51 B | ||||
| EBITDA | 713.56 M | ||||
| Net Income | 179.5 M | ||||
| Total Debt | 4.07 B | ||||
| Book Value Per Share | 64.88 X | ||||
| Cash Flow From Operations | 91.27 M | ||||
| Earnings Per Share | 2.08 X | ||||
| Market Capitalization | 15.28 B | ||||
| Total Asset | 13.56 B | ||||
| Retained Earnings | 5.61 B | ||||
| Working Capital | 1.55 B | ||||
About Revvity Performance
Evaluating Revvity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Revvity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Revvity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 116.13 | 121.94 | |
| Return On Tangible Assets | 0.16 | 0.08 | |
| Return On Capital Employed | 0.03 | 0.03 | |
| Return On Assets | 0.06 | 0.06 | |
| Return On Equity | 0.10 | 0.12 |
Things to note about Revvity performance evaluation
Checking the ongoing alerts about Revvity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Revvity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 91.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Laboratory Information Management System Market Size to Hit USD 4.61 Billion by 2032, Growing at a CAGR of 8.12 percent - SNS Insider |
- Analyzing Revvity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Revvity's stock is overvalued or undervalued compared to its peers.
- Examining Revvity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Revvity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Revvity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Revvity's stock. These opinions can provide insight into Revvity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Revvity Stock Analysis
When running Revvity's price analysis, check to measure Revvity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revvity is operating at the current time. Most of Revvity's value examination focuses on studying past and present price action to predict the probability of Revvity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revvity's price. Additionally, you may evaluate how the addition of Revvity to your portfolios can decrease your overall portfolio volatility.